Evidence is mounting that something happens when youth start working that compels them to smoke. With this trend in mind, it's worth exploring potential strategies to prevent smoking among youth who enter the workforce.
At this point, asking the FDA to restrict marketing or to ban flavored products would be premature. The base of scientific evidence is growing, particularly with e-cigarettes, but it doesn't support additional regulatory action beyond what the FDA has already proposed.
Currently, evidence for the safety, harmfulness, utility, and addictiveness of e-cigarettes is lacking. The questions that research needs to answer, however, are clear as day—particularly since business is booming.
The present study examined smoking prevalence and the demographic, clinical and psychosocial characteristics associated with smoking among a sample of Veterans Affairs primary care patients with probable major depression.
CVS Caremark will stop selling cigarettes and other tobacco products at its CVS/pharmacy stores beginning Oct. 1. Though it stands to lose $2 billion dollars in annual revenue, CVS CEO Larry J. Merlo said that selling tobacco products is at odds with the company's mission of improving health outcomes.
Spotlight on 2013 is RAND Europe's annual review. This year's focus is trust, and we feature RAND Europe projects that support policymakers to gain trust at three levels: from strategic challenges, through robust methods, to effective delivery.
This chapter uses field experience from a theory-based program, Project ALERT, to suggest possible strategies for enhancing program attractiveness to potential adopters and users, facilitating program fidelity while maintaining room for adaptation and taking a program to scale.
College students documented their exposure to pro-smoking media messages during their normal routine over a three-week period. After exposure to just one, their smoking intentions immediately increased by an average of 22 percent. Smoking intentions decreased with each passing day but remained elevated for seven days.
Racially/ethnically diverse preadolescent children share many of the same risk factors for smoking that have been found in studies of older children. Therefore, antismoking policies and programs might be more effective if designed for preadolescents as well as adolescents.
Anti-tobacco policies that have clear scientific support will strengthen the FDA's regulatory position. While the evidence base is solid in this area, it needs to be much stronger and broader if the TCA is going to have any lasting success against the industry.
The evidence on the availability and use in Europe of diverse tobacco and nicotine products such as waterpipes and new products such as electronic cigarettes or dissolvable smokeless tobacco is patchy, with high variability in both the quality of data and the regulatory environment.